Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2019 $ 55,100 $ 359 $ 242,442 $ (5) $ (3,393) $ (184,303)
Beginning balance, shares at Jan. 31, 2019   35,946,100        
Issuance of common stock pursuant to acquisition of Xstream 874 $ 5 869      
Issuance of common stock pursuant to acquisition of Xstream, shares   541,738        
Issuance of common stock pursuant to vesting of restricted stock units   $ 6 (6)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   608,200        
Issuance of common stock pursuant to ESPP purchases 20   20      
Issuance of common stock pursuant to ESPP purchases, shares   12,453        
Issuance of common stock pursuant to exercise of stock options 594 $ 3 591      
Issuance of common stock pursuant to exercise of stock options, shares   195,461        
Repurchases of common stock (142)     (142)    
Stock-based compensation expense 1,151   1,151      
Unrealized gains (losses) on marketable securities 44       44  
Foreign currency translation adjustment 1,212       1,212  
Net loss (8,921)         (8,921)
Ending balance at Jan. 31, 2020 49,932 $ 373 245,067 (147) (2,137) (193,224)
Ending balance, shares at Jan. 31, 2020   37,303,952        
Issuance of common stock pursuant to vesting of restricted stock units   $ 5 (5)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   462,300        
Issuance of common stock pursuant to ESPP purchases 18   18      
Issuance of common stock pursuant to ESPP purchases, shares   5,702        
Issuance of common stock pursuant to exercise of stock options $ 119   119      
Issuance of common stock pursuant to exercise of stock options, shares 39,270 39,270        
Repurchases of common stock $ (80)     (80)    
Stock-based compensation expense 1,247   1,247      
Unrealized gains (losses) on marketable securities (50)       (50)  
Foreign currency translation adjustment 2,114       2,114  
Net loss (21,759)         (21,759)
Ending balance at Jan. 31, 2021 $ 31,541 $ 378 $ 246,446 $ (227) $ (73) $ (214,983)
Ending balance, shares at Jan. 31, 2021   37,811,224